Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

This study has been completed.
Sponsor:
Collaborators:
Sahlgrenska University Hospital, Sweden
AstraZeneca
Information provided by:
Umeå University
ClinicalTrials.gov Identifier:
NCT00282178
First received: January 24, 2006
Last updated: October 15, 2008
Last verified: June 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2006
  Primary Completion Date: March 2006 (Final data collection date for primary outcome measure)